According to a study published in the British Medical Journal, results showed consistency across analyses reviewed that most estimates of symptom changes were close to zero and not significant.
Mental health may have not been as affected by COVID-19 as many would think.
According to a recent study published in the British Medical Journal, mental health worsened minimally when comparing patient’s health outcomes before, during and after the pandemic.
After reviewing over 94,400 unique titles and abstracts including 137 studies from 134 cohorts, researchers found there were no changes found for general mental health or anxiety symptoms, but depression symptoms worsened minimally.
Researchers conducted this search to rest concerns about COVID-19-related mental health as low-volume of evidence has become a barrier to evidence and decision-making, the study said. Many cross-sectional studies have reported numbers of participants with a prevalence of mental health problems; however, none have been compared to instances before the pandemic.
Results from the study shared most of the reports reviewed were from high income (77%) or upper middle income (20%) countries.
Among women or female participants, general mental health, anxiety and depression symptoms worsened by minimal to small amounts. Some subgroups found in the study other than women were parents and sexual and gender minorities who experienced mental health declines, but these declines were relatively small.
In 27 other analyses, five suggested symptoms worsened by minimal amounts, and two suggested minimal or small improvements. No other subgroup experienced changes across all outcome domains. For example, in three studies with data from March to April 2020 and late 2020, symptoms were unchanged from pre-COVID-19 levels at both assessments and increased initially then returned to pre-COVID-19 levels.
In addition, the study showed consistency across the analyses reviewed that most estimates of symptom changes were close to zero and not significant. Changes identified were minimal to small. Among general population studies, changes in general mental health or anxiety symptoms, and the worsening of depression symptoms were minimal.
Researchers claim there were some limitations to the study including the lack of evidence of a large-scale decline in mental health. The lack of evidence could be because “people are resilient and have made the best of a difficult situation.” The minimal changes could also reflect steps that governments have taken to support mental health.
The World Health Organization, other pan-national organizations, and governments across the globe have produced strategies for dealing with mental health and have invested in resources to support public mental health, even in countries where mental health had not been a priority previously, the study said.
Latest Vaccines and Antiviral Treatments Show Promising Results in Reducing Severe COVID Outcomes
March 7th 2024It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
How More Prompt Action Could Have Saved Thousands of U.S. COVID-19 Deaths
December 10th 2023Researchers of a study compared Israel's CVOID-19 booster rollout experience to the United States to ask the question: How many lives could the U.S. have saved if boosters were authorized sooner?
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
A Cup or Two of Joe a Day Could Keep COVID-19 Infection Away
November 19th 2023Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
Read More
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More